Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GIKLY is expected to report earnings to fall 28.40% to 8 cents per share on May 12
Q1'25
Est.
$0.08
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Est.
$0.04
Q1'24
Missed
by $0.04
The last earnings report on February 26 showed earnings per share of 11 cents, beating the estimate of 10 cents. With 326.00 shares outstanding, the current market capitalization sits at 8.78B.